Predictions
Novacyt S.A.
Start price
Target price
Perf. (%)
€10.10
19.10.20
19.10.20
€4.00
30.10.20
30.10.20
14.26%
30.10.20
30.10.20
Probably not worthwhile Investment
Novacyt S.A.
Start price
Target price
Perf. (%)
€10.10
19.10.20
19.10.20
-
04.11.21
04.11.21
-72.31%
05.11.21
05.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Heat Biologics Inc.
Start price
Target price
Perf. (%)
€7.29
19.10.20
19.10.20
€14.00
31.10.20
31.10.20
1.63%
31.10.20
31.10.20
Genmark Diagnostics
Start price
Target price
Perf. (%)
€9.65
19.10.20
19.10.20
€12.00
02.11.20
02.11.20
12.95%
02.11.20
02.11.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€12.20
19.10.20
19.10.20
€15.00
02.11.20
02.11.20
-6.56%
02.11.20
02.11.20
Could be worthwhile Investment >10% per year
Cutera Inc.
Start price
Target price
Perf. (%)
€16.30
19.10.20
19.10.20
€20.00
02.11.20
02.11.20
-0.61%
02.11.20
02.11.20
Could be worthwhile Investment >10% per year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
19.10.20
19.10.20
€10.00
02.11.20
02.11.20
-
02.11.20
02.11.20
Could be very worthwhile Investment >20% year
Epigenomics AG NA
Start price
Target price
Perf. (%)
€0.51
18.10.20
18.10.20
€1.00
02.11.20
02.11.20
20.00%
02.11.20
02.11.20
Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Innovative
GNI Group Ltd
Start price
Target price
Perf. (%)
€24.00
18.10.20
18.10.20
€12.00
04.11.21
04.11.21
-35.42%
26.06.21
26.06.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
Below average Management
Little innovation
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€5.70
18.10.20
18.10.20
€2.00
04.11.21
04.11.21
-35.79%
26.06.21
26.06.21
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Acelrx Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€31.82
18.10.20
18.10.20
-
31.10.20
31.10.20
-7.45%
31.10.20
31.10.20
Risky Investment
Dr. Reddy's Laboratories Ltd. ADR
Start price
Target price
Perf. (%)
€57.50
18.10.20
18.10.20
€65.00
04.11.21
04.11.21
-3.48%
05.11.21
05.11.21